The Best Buy business continues to make inroads into the home healthcare space and will soon start selling prescription continuous glucose monitoring systems.
The consumer electronics giant said it will soon start selling prescription continuous glucose monitoring systems (CGMs) delivered directly to the customer’s home. It marks the first time that Best Buy will offer prescription-based medical devices.
Best Buy will sell the Dexcom G7 CGM via BestBuy.com, where customers will be directed to the retailer’s new platform, Wellness.BestBuyHealth.com, to complete the process. Best Buy is selling the monitors via a site powered by Salesforce’s Commerce Cloud platform.
Going forward, Best Buy said its goal is to soon allow customers with an existing CGM prescription from their own physician to be able to upload that prescription into their profile and have the device sent to them. It also noted it is aiming to offer more CGM system options after the initial launch.
More than 10 per cent of the US population has diabetes according to data from the Centers for Disease Control and Prevention, Best Buy said in a statement.
“With the demand for CGM growing over the past few years, using devices like Dexcom G7 means no fingersticks, real-time glucose monitoring and the ability to make smarter decisions about controlling diabetes,” the company added.
